Jane Street’s Utah Medical Products UTMD Stock Holding History

Jane Street’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,440	Closed	-$416K	–	13068
2025 Q4	$416K	Buy	7,440 +3,901	+110%	+$226K	﹤0.01%	8111
2025 Q3	$223K	Buy	+3,539	New	+$209K	﹤0.01%	9463
2025 Q2	–	Sell	-5,653	Closed	-$317K	–	10983
2025 Q1	$317K	Buy	+5,653	New	+$339K	﹤0.01%	7711
2024 Q4	–	Sell	-3,127	Closed	-$209K	–	10665
2024 Q3	$209K	Sell	3,127 -2,752	-47%	-$187K	﹤0.01%	8585
2024 Q2	$393K	Buy	5,879 +2,266	+63%	+$154K	﹤0.01%	7404
2024 Q1	$257K	Buy	+3,613	New	+$271K	﹤0.01%	7792
2021 Q2	–	Sell	-2,311	Closed	-$200K	–	10451
2021 Q1	$200K	Buy	+2,311	New	+$203K	﹤0.01%	8272

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's UTMD Position: Q1 2026 in Review

Jane Street sold out of Utah Medical Products (UTMD) in Q1 2026, closing a stake of 7,440 shares — an estimated $416K sold.

Jane Street first reported a position in UTMD in Q1 2021 and held it in 7 quarters. The position peaked at $416K in Q4 2025. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Jane Street reported no remaining Utah Medical Products position as of Q1 2026 after selling out during the quarter.
Jane Street sold 7,440 Utah Medical Products shares in Q1 2026, an estimated $416K.
Jane Street first reported a position in Utah Medical Products in Q1 2021 and held it in 7 quarters.
Jane Street's Utah Medical Products position peaked at $416K in Q4 2025.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.